Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

857 ARTÍCULOS , VIENDO DEL 841 AL 855

Delirium derived from dementia with Lewy bodies in the cancer perioperative period: a case report

Yamaguchi J, Sadahiro R, Wada S, Nishikawa E, Terada T, Nakahara R, Matsuoka H.

Ann Palliat Med. 2025 Sep;14(5):508-513. doi: 10.21037/apm-25-48.

Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank

Casanova F, Tian Q, Williamson DS, Lucas MR, Zweibaum D, Ding J, Atkins JL, Melzer D, Ferrucci L, Pilling LC.

J Alzheimers Dis. 2025 Nov;108(1):107-118. doi: 10.1177/13872877251375432. Epub 2025 Sep 15.

Pharmacological strategies for managing dementia with Lewy bodies: an expert review of symptom-targeted care

Atewogboye O, Taylor JP, Harrison JR.

Expert Rev Clin Pharmacol. 2025 Sep;18(9):645-653. doi: 10.1080/17512433.2025.2562151. Epub 2025 Sep 19.

Apathy linked to higher amyloid burden and cognitive deterioration in Parkinson's disease

Gasca-Salas C, Fernández-Fernández R, Rodríguez-Rojas R, Fernández-Rodríguez B, García-Cañamaque L, Lahera G, Trompeta C.

J Parkinsons Dis. 2025 Dec;15(8):1452-1464. doi: 10.1177/1877718X251370969. Epub 2025 Sep 17.

Prevention of cognitive impairment and dementia in people with Parkinson's disease: A call-to-action

Kalbe E, Warnecke T, Eggers C, Ophey A, Folkerts AK.

J Parkinsons Dis. 2025 Dec;15(8):1353-1366. doi: 10.1177/1877718X251365769. Epub 2025 Oct 1.

Risk Factors for Dementia in a Sample of Patients From a Quaternary Care Hospital Network in the United Arab Emirates: A Case-control Study

Dhillon A, Fazal J.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):331-333. doi: 10.1097/WAD.0000000000000691. Epub 2025 Oct 6.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P.

Schizophr Bull. 2025 Oct 6;51(Supplement_3):S273-S291. doi: 10.1093/schbul/sbaf068.

Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review

Liu RY, Yin KF, He SY, Su WM, Duan QQ, Wen XJ, Chen T, Shen C, Li JR, Cao B, Chen YP.

Transl Psychiatry. 2025 Oct 10;15(1):388. doi: 10.1038/s41398-025-03639-2.

Repetitive transcranial magnetic stimulation for cognitive and emotional symptoms in neurodegenerative diseases: a systematic review and dose-response meta-analysis

Zhang Y, Liu S, Xu K, Shen Y, Liu Z, Wang Y, Bai Y, Wang S.

Neurol Sci. 2025 Dec;46(12):6243-6259. doi: 10.1007/s10072-025-08531-x. Epub 2025 Nov 5.

Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies

Aung KZ, Zin SS, Wu X, Myint ZW, Karanth S, Estus S, Norris CM, Nelson PT, Fardo DW, Abner EL, Katsumata Y.

Neurobiol Dis. 2025 Dec;217:107190. doi: 10.1016/j.nbd.2025.107190. Epub 2025 Nov 13.

Digital App for Speech and Health Monitoring Study (DASH): protocol for a prospective longitudinal case-control observational study for developing speech datasets in neurodegenerative disorders and dementia

Tam J, Weaver C, Ihenacho A, Newton J, Virgo B, Barrett S, Neale J, Perry D, Smith A, Chandran S, Watts O, Pal S; DASH Consortium.

BMJ Open. 2025 Dec 5;15(12):e100222. doi: 10.1136/bmjopen-2025-100222.

The orexin/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment

Zhuang C, Cao Y, Lu J, Zhou Y, Liu Y, Li Y.

Psychopharmacology (Berl). 2025 Oct;242(10):2161-2179. doi: 10.1007/s00213-025-06839-2. Epub 2025 Jun 16.

Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease

Petrillo J, Sawant R, Rogers R, Cleanthous S, Cano S, Kumar R, Klapper J, Sierra LA, Bang J, Anderson KE, Hall DA, Perlman S, Moore H, Bega D, Johannesen J, Elliott E.

J Huntingtons Dis. 2025 Nov;14(4):369-381. doi: 10.1177/18796397251358375. Epub 2025 Jul 22.

Efficacy and safety of cholinesterase inhibitors and memantine for cognitive symptoms in patients with Huntington's disease: A systematic review

Rodrigues CC, Carvalho V, Sotero FD, Mulroy E, Guedes LC.

J Huntingtons Dis. 2025 Nov;14(4):331-339. doi: 10.1177/18796397251367689. Epub 2025 Aug 12.

A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington's disease

Moreu-Valls A, Puig-Davi A, Martinez-Horta S, Kulisevsky G, Sampedro F, Perez-Perez J, Horta-Barba A, Olmedo-Saura G, Pagonabarraga J, Kulisevsky J.

J Neurol. 2025 Feb 12;272(3):202. doi: 10.1007/s00415-025-12927-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias